z-logo
open-access-imgOpen Access
Diagnosis, pathogenesis and treatment of myositis: recent advances
Author(s) -
Carstens P. O.,
Schmidt J.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12194
Subject(s) - pathogenesis , myositis , medicine , pathology
Summary Dermatomyositis ( DM ), polymyositis ( PM ), necrotizing myopathy ( NM ) and inclusion body myositis ( IBM ) are four distinct subtypes of idiopathic inflammatory myopathies – in short myositis. Recent studies have shed some light on the unique pathogenesis of each entity. Some of the clinical features are distinct, but muscle biopsy is indispensable for making a reliable diagnosis. The use of magnetic resonance imaging of skeletal muscles and detection of myositis‐specific autoantibodies have become useful additions to our diagnostic repertoire. Only few controlled trials are available to substantiate current treatment approaches for myositis and hopes are high that novel modalities will become available within the next few years. In this review we provide an up‐to‐date overview of the pathogenesis and diagnostic approach of myositis. We aim to present a guide towards therapeutic and general management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom